1%3A20-cv-00755 - United Therapeutics Corp v. Liquidia Technologies IncReport Error
Detail
Case Number
1:20-cv-00755Current Status
closedCause of Action
Patent Infringement
Related Case(s)
1:21-cv-00489
1:21-mc-00325
2022-2217
Court
Delaware District CourtPlaintiff(s)
United Therapeutics Corp
Operating CompanyDefendant(s)
Liquidia Technologies Inc
Judge
Richard G. AndrewsFiling Date
2020-06-04Termination Date
2022-09-09Dockets
Text |
---|
CIVIL DOCKET |
Final Civil Docket 09-09-2022 |
CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court`s Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) (Entered: 04/04/2022) |
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) (Entered: 08/05/2020) |
CORRECTING ENTRY: D.I. 396 removed re filing error. (lak) (Entered: 04/13/2022) |
CORRECTING ENTRY: Exhibit 44 has been added to the brief filed at D.I. 303 as it was inadvertently omitted at the initial time of filing. Defendant has confirmed the exhibit has been served on Plaintiff. (nms) (Entered: 02/14/2022) |
CORRECTING ENTRY: The Notice of Service filed at D.I. 157 has been removed from the docket. The filing was incompletely formatted. The first page of the filing was counsel's signature. No where could it be found a captioned cover page or a description of what was actually being served. (nms) (Entered: 08/16/2021) |
CORRECTING ENTRY: The Oral Order at D.I. 95 has been corrected to refer to Fed. R. Civ. P. 26. (ceg) (Entered: 05/19/2021) |
CORRECTING ENTRY: The exhibits filed on 2/28/2022, at D.I. 321 have been removed from the docket. The filing lacked a proper captioned cover page. Counsel is to refile the exhibits accordingly. (nms) (Entered: 03/01/2022) |
CORRECTING ENTRY: The main pdf for D.I. 99 has been replaced per counsel's request. The numbering in table of contents has been corrected. (nms) (Entered: 05/24/2021) |
CORRECTING ENTRY: The pdf for D.I. 228 has been replaced per counsel's request. The NEF for the filing has been regenerated. (nms) (Entered: 11/12/2021) |
CORRECTING ENTRY: The pdf for D.I. 415 has been replaced per counsel`s request. Typographical errors have been corrected. The NEF for the filing has been regenerated. (nms) (Entered: 06/16/2022) |
CORRECTING ENTRY: The pdf for Exhibits 1-2, P1-P6 found at D.I. 76 has been replaced with a corrected version per counsel's request. Attachments to Exhibit P4 have been added as they were inadvertently omitted at the time of filing. (nms) (Entered: 06/01/2021) |
CORRECTING ENTRY: The pdf for the Redacted Letter at D.I. 199 has been replaced with a corrected version per counsel's request. (ceg) (Entered: 10/06/2021) |
CORRECTING ENTRY: The pdf for the exhibits found at D.I. 355 has been replaced with a corrected version per the filers request. (nms) (Entered: 03/01/2022) |
CORRECTING ENTRY: The pdf for the letter at D.I. 208 has been replaced per counsel's request. The NEF for the filing has been regenerated. (ceg) (Entered: 10/13/2021) |
CORRECTING ENTRY: The pdfs for Exhibits 33, 41, 42, and 43 found at D.I. 303 have been replaced with corrected versions. Exhibits 33 and 41 have been amended to reflect typographical errors, and exhibits 42 and 43 have been pared down. Opposing counsel has agreed to the corrections and has been reserved with the exhibits. (nms) (Entered: 02/23/2022) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 06/10/2020) |
DEFICIENCY NOTICE by the Court issued to United Therapeutics Corporation re 323 Sealed Motion in Limine, and 325 Sealed Motion in Limine. Upon review it was determined these sealed filings do not comply with Local Rule 5.2(b)(1). Plaintiff is requested to supplement the docket with an appropriate certificate of service. (nms) (Entered: 03/01/2022) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Combined Discovery Dispute Teleconference held on 9/22/2021 re Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharmas Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1). (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg) (Entered: 09/22/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 11/18/2021. (*Court Reporter Heather Triozzi.) (ceg) (Entered: 11/18/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 11/4/2021. (*Court Reporter Stacy Ingram.) (ceg) (Entered: 11/04/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 12/14/2021. (*Court Reporter Deanna Warner.) (ceg) (Entered: 12/14/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 12/6/2021. (*Court Reporter Deanna Warner.) (ceg) (Entered: 12/07/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 6/8/2021. (*Court Reporter Jennifer Guy.) (ceg) (Entered: 06/08/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery/Protective Order Dispute Teleconference held on 10/14/2021. (*Court Reporter Stacy Ingram.) (ceg) (Entered: 10/14/2021) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 3/10/2022 via video conference re 281 Defendant's Motion for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel. (*Court Reporter Deanna Warner.) (ceg) (Entered: 03/10/2022) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference held on 3/11/2022. The Court read from the bench its Report & Recommendation on the pending Motion for Summary Judgment. (*Court Reporter Heather Triozzi.) (ceg) (Entered: 03/11/2022) |
Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference re 81 Motion for Issuance of a Letter of Request for International Judicial Assistance held on 6/21/2021. (*Court Reporter Stacy Vickers.) (ceg) (Entered: 06/21/2021) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 1 held on 3/28/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Opening statements made. Witnesses: Patrick Poisson, deposition of Jeffrey Kindig, deposition of Todd Battistoni, Dr. Colin Nuckolls, Dr. F. Dean Toste, deposition of Kelli Collin, deposition of Marisa Law, Cesar Matto, deposition of Dr. Benjamin Maynor, deposition of Robert Roscigno, deposition of Dr. Werner Seeger. (Court Reporter Heather Triozzi.) (lak) (Entered: 03/29/2022) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 2 held on 3/29/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Witnesses: Jeffrey Kindig, deposition of Hamilton Lennox, John Fuson, Dr. Jeffrey Winkler, deposition of Dr. Hitesh Batra, deposition of Dr. Sudersan Tuladhar, Dr. Nicholas Hill, deposition of Dr. Lewis Rubin. (Court Reporter Heather Triozzi.) (lak) (Entered: 03/30/2022) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 3 held on 3/30/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Witnesses: Dr. Aaron Waxman, Dr. Nicholas Hill, Dr. Igor Gonda, Dean Bunce, Dr. David Walsh, Dr. Karl Scheidt, Dr. Andrew Clark, Dr. Hugh Smyth. (Court Reporter Heather Triozzi.) (lak) (Entered: 03/31/2022) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 4 completed on 3/31/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Closing arguments made. (Court Reporter Heather Triozzi.) (lak) (Entered: 04/04/2022) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 6/4/2021. Counsel for Plaintiff: M. Flynn. Counsel for Defendant: K. Keller. The parties shall submit a proposed order on the first 3 terms covered in the markman hearing. The parties shall file a joint submission for the 2 remaining claim terms on 6/18/2021. (Court Reporter Patrick O'Hare.) (lak) (Entered: 06/04/2021) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 3/4/2022. Counsel for Plaintiff: M. Flynn. Counsel for Defendant: H. Hoeschen. The parties shall submit a revised pretrial order by the end of next week. A few days before the start of the trial, the parties are directed to provide the Court with binders of the witnesses they intend to call. (Court Reporter Heather Triozzi.) (lak) (Entered: 03/04/2022) |
Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Conference held on 7/30/2020. Counsel for Plaintiff: J. Blumenfeld. Counsel for Defendant: K. Keller. (Court Reporter Heather Triozzi.) (lak) (Entered: 07/30/2020) |
Motions No Longer Referred: 311 MOTION for Presumption Under 35 U.S.C § 295. (nms) (Entered: 02/24/2022) |
Motions No Longer Referred: 81 MOTION for Issuance of Letters Rogatory for International Judicial Assistance, and 80 Joint Motion for Claim Construction. (nms) (Entered: 05/03/2021) |
Pro Hac Vice Attorney Adam M. Pivovar for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) (Entered: 01/13/2022) |
Pro Hac Vice Attorney Art P. Dykhuis for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 11/06/2020) |
Pro Hac Vice Attorney Brittany Cazakoff for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 06/16/2021) |
Pro Hac Vice Attorney Douglas H. Carsten for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) (Entered: 06/12/2020) |
Pro Hac Vice Attorney Joshua Mack for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) (Entered: 06/12/2020) |
Pro Hac Vice Attorney Katherine Pappas for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 07/07/2021) |
Pro Hac Vice Attorney Timothy M. Dunker, Jiaxiao Zhang, and William C. Jackson for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) (Entered: 06/07/2021) |
Pro Hac Vice Attorneys Sanya Sukduang, Jonathan R. Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl, Deepa Kannappan for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 07/17/2020) |
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of D.I. # 222 . (ceg) (Entered: 11/09/2021) |
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 110 . (nms) (Entered: 06/15/2021) |
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 76 , 77 , 78 , 79 , and 82 . (nms) (Entered: 05/11/2021) |
SO ORDERED, 231 Stipulation to Extend Time to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter (D.I. 226) to November 17, 2021. ORDERED by Judge Jennifer L. Hall on 11/12/2021. (ceg) (Entered: 11/12/2021) |
SO ORDERED, 239 Stipulation to Extend Time to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter to November 18, 2021. ORDERED by Judge Jennifer L. Hall on 11/19/2021. (ceg) (Entered: 11/19/2021) |
SO ORDERED, re 10 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Liquidia Technologies, Inc. answer due 7/27/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms) (Entered: 06/26/2020) |
SO ORDERED, re 103 MOTION for Pro Hac Vice Appearance of Attorney Joshua Revilla, Jiaxiao Zhang, Katherine Pappas and Timothy Dunker of MCDERMOTT WILL & EMERY LLP, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/1/2021. (nms) (Entered: 06/01/2021) |
SO ORDERED, re 115 STIPULATION to Extend Time (*Reset Briefing Schedule: re 109 MOTION for Leave to File a Second Amended Complaint. Answering Brief due 7/2/2021). Signed by Judge Richard G. Andrews on 6/14/2021. (nms) (Entered: 06/14/2021) |
SO ORDERED, re 118 MOTION for Pro Hac Vice Appearance of Attorney Brittany Cazakoff, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 6/16/2021. (nms) (Entered: 06/16/2021) |
SO ORDERED, re 122 STIPULATION to Extend Time for the parties to file their joint supplemental claim construction brief to June 21, 2021 (*Reset Deadlines: Joint Supplemental Claim Construction Brief due by 6/21/2021). Signed by Judge Richard G. Andrews on 6/21/2021. (nms) (Entered: 06/21/2021) |
SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 7/17/2020. (nms) (Entered: 07/17/2020) |
SO ORDERED, re 132 STIPULATION to Extend Time (*Reset Briefing Schedule: re 109 MOTION for Leave to File a Second Amended Complaint. Reply Brief due 7/15/2021). Signed by Judge Richard G. Andrews on 7/6/2021. (nms) (Entered: 07/06/2021) |
SO ORDERED, re 169 MOTION for Pro Hac Vice Appearance of Attorney Huiya Wu, Joel Broussard and Harrison Gunn, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 9/8/2021. (nms) (Entered: 09/08/2021) |
SO ORDERED, re 183 MOTION for Pro Hac Vice Appearance of Attorney Amy Mahan, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 9/22/2021. (nms) (Entered: 09/22/2021) |
SO ORDERED, re 216 STIPULATION TO EXTEND TIME to submit proposed public versions of discovery dispute letters to October 21, 2021. Signed by Judge Richard G. Andrews on 10/21/2021. (nms) (Entered: 10/21/2021) |
SO ORDERED, re 236 STIPULATION to Extend Time (*Reset Briefing Schedule: re 224 MOTION for Leave to Move for Summary Judgment. Answering Brief due 11/23/2021). Signed by Judge Richard G. Andrews on 11/17/2021. (nms) (Entered: 11/17/2021) |
SO ORDERED, re 24 STIPULATION TO EXTEND TIME to submit a Protective Order to August 14, 2020. Signed by Judge Richard G. Andrews on 8/10/2020. (nms) (Entered: 08/10/2020) |
SO ORDERED, re 249 STIPULATION TO EXTEND TIME to file a reply brief (*Reset Briefing Schedule: re 224 MOTION for Leave to Move for Summary Judgment. Reply Brief due 12/7/2021). Signed by Judge Richard G. Andrews on 11/29/2021. (nms) (Entered: 11/29/2021) |
SO ORDERED, re 251 STIPULATION TO EXTEND TIME to submit a proposed public version to December 2, 2021. Signed by Judge Richard G. Andrews on 12/1/2021. (nms) (Entered: 12/01/2021) |
SO ORDERED, re 258 STIPULATION TO EXTEND TIME to submit proposed public versions of the parties respective discovery dispute letters (D.I. 254 and 255) to December 13, 2021. Signed by Judge Richard G. Andrews on 12/10/2021. (nms) (Entered: 12/10/2021) |
SO ORDERED, re 263 STIPULATION TO EXTEND TIME to submit a proposed public version to December 15, 2021. Signed by Judge Richard G. Andrews on 12/14/2021. (nms) (Entered: 12/14/2021) |
SO ORDERED, re 269 STIPULATION to Extend Time to submit a proposed public version of Reply Brief (D.I. 257 ) to December 17, 2021. Signed by Judge Richard G. Andrews on 12/15/2021. (nms) (Entered: 12/15/2021) |
SO ORDERED, re 270 STIPULATION TO EXTEND TIME to submit a proposed public version of letter (D.I. 255 ) to December 16, 2021. Signed by Judge Richard G. Andrews on 12/16/2021. (nms) (Entered: 12/16/2021) |
SO ORDERED, re 272 STIPULATION to Extend Time to submit a public version of Reply Brief (D.I. 257) to December 21, 2021. Signed by Judge Richard G. Andrews on 12/20/2021. (nms) (Entered: 12/20/2021) |
SO ORDERED, re 277 MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 12/28/2021. (nms) (Entered: 12/28/2021) |
SO ORDERED, re 280 MOTION for Pro Hac Vice Appearance of Attorney Adam Pivovar, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 1/5/2022. (nms) (Entered: 01/05/2022) |
SO ORDERED, re 283 STIPULATION to Extend Time (*Reset Briefing Schedule: re 281 MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel. Answering Brief due 1/28/2022, Reply Brief due 2/11/2022). Signed by Judge Richard G. Andrews on 1/11/2022. (nms) (Entered: 01/11/2022) |
SO ORDERED, re 284 STIPULATION TO EXTEND TIME to take the depositions of Plaintiff's expert witnesses Cesar Matto and Hugh Smyth to January 21, 2022, and January 19, 2022, respectively. Signed by Judge Richard G. Andrews on 1/14/2022. (nms) (Entered: 01/14/2022) |
SO ORDERED, re 285 STIPULATION TO EXTEND TIME to file a redacted version of Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 21, 2022. Signed by Judge Richard G. Andrews on 1/14/2022. (nms) (Entered: 01/14/2022) |
SO ORDERED, re 287 STIPULATION TO EXTEND TIME to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 28, 2022. Signed by Judge Richard G. Andrews on 1/24/2022. (nms) (Entered: 01/24/2022) |
SO ORDERED, re 299 MOTION for Pro Hac Vice Appearance of Attorney Kyung Taeck Minn, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 2/8/2022. (nms) (Entered: 02/08/2022) |
SO ORDERED, re 316 STIPULATION TO EXTEND TIME to file a redacted version of its Opening Discovery Dispute Letter to February 25, 2022. Signed by Judge Richard G. Andrews on 2/23/2022. (nms) (Entered: 02/23/2022) |
SO ORDERED, re 329 STIPULATION to Extend Time to submit redacted filings to March 8, 2022. Signed by Judge Richard G. Andrews on 3/2/2022. (nms) (Entered: 03/02/2022) |
SO ORDERED, re 338 STIPULATION to Extend Time to submit proposed public versions of the Joint Proposed Pretrial Order (D.I. 322), as well as motions in limine and accompanying exhibits (D.I. 323-326) to March 18, 2022. Signed by Judge Richard G. Andrews on 3/8/2022. (nms) (Entered: 03/08/2022) |
SO ORDERED, re 347 STIPULATION to Extend Time to submit redacted documents to March 18, 2022. Signed by Judge Richard G. Andrews on 3/11/2022. (nms) (Entered: 03/11/2022) |
SO ORDERED, re 354 STIPULATION to Extend Time to submit proposed public versions to March 22, 2022. Signed by Judge Richard G. Andrews on 3/15/2022. (nms) (Entered: 03/15/2022) |
SO ORDERED, re 366 STIPULATION TO EXTEND TIME to submit proposed public versions of United Therapeutics Corporation`s Motion in Limine No. 1 and accompanying exhibits (D.I. 323-324) to March 22, 2022. Signed by Judge Richard G. Andrews on 3/21/2022. (nms) (Entered: 03/21/2022) |
SO ORDERED, re 368 MOTION for Pro Hac Vice Appearance of Attorney Ian B. Brooks, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 3/21/2022. (nms) (Entered: 03/21/2022) |
SO ORDERED, re 369 MOTION for Pro Hac Vice Appearance of Attorney Eric Levi, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 3/21/2022. (nms) (Entered: 03/21/2022) |
SO ORDERED, re 376 STIPULATION to Extend Time to File Redacted Filing to March 25, 2022. Signed by Judge Richard G. Andrews on 3/23/2022. (nms) (Entered: 03/23/2022) |
SO ORDERED, re 383 STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.`s Objection to Report and Recommendation (D.I. 377) to April 13, 2022. Signed by Judge Richard G. Andrews on 3/31/2022. (nms) (Entered: 03/31/2022) |
SO ORDERED, re 384 STIPULATION to Extend Time to file its response to Objections to Report & Recommendation to April 13, 2022. Signed by Judge Richard G. Andrews on 4/1/2022. (nms) (Entered: 04/01/2022) |
SO ORDERED, re 392 STIPULATION to Extend Time to submit a final list of exhibits admitted at trial to April 8, 2022. Signed by Judge Richard G. Andrews on 4/8/2022. (nms) (Entered: 04/08/2022) |
SO ORDERED, re 393 STIPULATION to Extend Time to submit a final list of exhibits admitted at trial to April 11, 2022. Signed by Judge Richard G. Andrews on 4/11/2022. (nms) (Entered: 04/11/2022) |
SO ORDERED, re 42 MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 10/26/2020. (nms) (Entered: 10/26/2020) |
SO ORDERED, re 46 MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 11/4/2020. (nms) (Entered: 11/04/2020) |
SO ORDERED, re 64 MOTION for Pro Hac Vice Appearance of Attorney Bill Ward, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 4/7/2021. (nms) (Entered: 04/07/2021) |
SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms) (Entered: 06/11/2020) |
SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms) (Entered: 06/11/2020) |
SO ORDERED, re Stipulation to Extend Time to file a joint status letter pursuant to the Court's order to October 8, 2021. (195 in 1:20-cv-00755-RGA-JLH, 10 in 1:21-mc-00377-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 10/4/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00377-RGA-JLH(ceg) (Entered: 10/04/2021) |
ORAL ORDER: The parties contacted chambers to advise of a discovery impasse. Pursuant to the Scheduling Order (D.I. 20 ) all discovery disputes including those that may arise in connection with expert reports are now REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 4/28/2021. (nms) Modified on 5/3/2021 (nms). (Entered: 04/28/2021) |
ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 4/28/2021. (ceg) (Entered: 04/28/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 73 ). A discovery dispute teleconference is scheduled for May 18, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than May 5, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than May 11, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 4/30/2021. (ceg) (Entered: 04/30/2021) |
ORAL ORDER: The Joint Motion for Claim Construction (D.I. 80 ) is GRANTED. The hearing will be limited to two hours. Signed by Judge Richard G. Andrews on 5/4/2021. (nms) (Entered: 05/04/2021) |
ORAL ORDER: Due to a scheduling conflict the Markman hearing scheduled for 5/24/2021, is CANCELED and the hearing is now reset for 6/4/2021, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 5/10/2021. (nms) (Entered: 05/10/2021) |
ORAL ORDER: Having carefully reviewed the parties' letters and attachments (D.I. 84 , 86 ) regarding the pending Motion for Teleconference to Resolve Discovery Dispute (D.I. 73 ) IT IS HEREBY ORDERED that Liquidia's request for an order compelling Dr. Ruffalo (or UTC counsel) to provide sworn responses to twelve questions is DENIED. It is evident that Liquidia's questions seek to determine if and when Dr. Ruffalo consulted with UTC's attorneys regarding briefs filed in IPRs concerning two of the patents-in-suit. (He did not testify in those proceedings.) Disclosure of that information in this proceeding is not required by Fed. R. Civ. P. 26(a)(2); the Court rejects any assertion that the answers to Liquida's questions constitute "facts or data considered by" Dr. Ruffalo in forming his opinions. The record also reflects that UTC has complied with its disclosure obligations under Fed. R. Civ. P. 26(a)(2). Moreover, the Court finds that, under the particular circumstances here, the disclosure of information regarding the fact and timing of Dr. Ruffalo's communications with UTC's attorneys would violate the spirit, if not the letter, of Fed. R. Civ. P. 26(b)(3),(4). The Court is unpersuaded by Liquidia's contention that its questions "seek basic information that would otherwise be included on a privilege log." (D.I. 84 at 3.) If the communications need not be logged, for example, because they were between outside counsel and Dr. Ruffalo, the Court will not require Dr. Ruffalo to answer questions about them. The teleconference scheduled for 5/18 is CANCELLED. SO ORDERED by Judge Jennifer L. Hall on 5/17/2021. (ceg) Modified docket text on 5/17/2021 (ceg). Modified docket text on 5/19/2021 (ceg). (Entered: 05/17/2021) |
ORAL ORDER: The Motion for Issuance of a Letter of Request for International Judicial Assistance (D.I. 81 ) is REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 5/24/2021. Motions referred to Jennifer L. Hall.(nms) (Entered: 05/24/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 98 ). A discovery dispute teleconference is scheduled for June 8, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than May 28, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than June 3, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 5/25/2021. (ceg) (Entered: 05/25/2021) |
ORAL ORDER: The Court will entertain oral argument on the pending Motion for Issuance of a Letter of Request for International Judicial Assistance at the discovery dispute hearing currently scheduled for June 8, 2021. Prior to the conference, the parties are ORDERED to meet and confer and discuss in detail each and every request set forth in Exhibits 1 and 2 of the proposed Letter of Request. Delaware counsel must attend the meet and confer. The meet and confer must cover at least the following issues (1) whether the information requested has now been produced; (2) whether any of the requests can and should be narrowed to cover only relevant information and/or reduce the burden on the third party and/or the foreign court; (3) whether three deponents are necessary and whether Plaintiff would be amenable to requesting testimony from a single corporate representative, if permitted by law; (4) whether the requested samples exist; and (5) how the parties' respective positions on the above issues promote the interests of judicial economy, comity, and the just resolution of this matter. The Court further provides the following guidance to aid the parties' discussion. The Court is not inclined to authorize Exhibit 2, Request No. 7. The Court is inclined to substantially narrow Exhibit 2, Request No. 3. If Plaintiff has reason to believe that some, but not all, of the requested manufacturing and analytical testing records (e.g., batch records) have been produced, the Court will likely authorize the corresponding requests notwithstanding that they may call for production of some duplicative information. The Court is not inclined to authorize Exhibit 1, Question 16. The Court is inclined to authorize the remaining 16 questions and is not inclined to rewrite them. To the extent that Plaintiff is requesting Yonsung to "provide samples that do not currently exist" or "make samples" (as Defendant suggests), the Court is not inclined to authorize such a request. ORDERED by Judge Jennifer L. Hall on 6/4/2021. (ceg) (Entered: 06/04/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the discovery dispute teleconference held on June 8, 2021 shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 6/8/2021. (ceg) (Entered: 06/08/2021) |
ORAL ORDER Setting Teleconference: A teleconference re 81 Motion for Issuance of a Letter of Request for International Judicial Assistance is scheduled for June 16, 2021 at 1:00 PM Eastern Time before Judge Jennifer L. Hall. By June 14, 2021, each side shall file a letter, not to exceed three pages, addressing any remaining disputes. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. ORDERED by Judge Jennifer L. Hall on 6/8/2021. (ceg) (Entered: 06/08/2021) |
ORAL ORDER Rescheduling Teleconference: Due to a conflict in the Court's calendar, IT IS HEREBY ORDERED that the teleconference scheduled for June 16, 2021 is RESCHEDULED for June 21, 2021 at 4:00 PM before Judge Jennifer L. Hall. ORDERED by Judge Jennifer L. Hall on 6/11/2021. (ceg) (Entered: 06/11/2021) |
Remark: Certified copies of the Order and Letter of Request will be available on June 22, 2021 for pick-up in the Clerk's Office. (ceg) (Entered: 06/21/2021) |
Remark: The additional Letter Request and Certified Translation have been signed and sealed by Judge Hall (See D.I. 136 ). The documents have been placed in the envelope provided by counsel for FedEx Express mailing. (ceg) (Entered: 07/14/2021) |
ORAL ORDER Setting Teleconference: Pending before the Court are the Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharmas Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1). A combined discovery dispute teleconference is scheduled for September 22, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. Briefing on the Motion to Quash shall occur in accordance with Judge Hall's standard discovery dispute procedures; the Court will not consider briefs previously filed. By no later than September 16, 2021, each party seeking relief in each dispute shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than September 20, 2021, any parties opposing each application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 9/13/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg) (Entered: 09/13/2021) |
ORAL ORDER: For the reasons stated in open court on September 22, 2021, the Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharma's Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1) are GRANTED IN PART and DENIED IN PART. The transcript of the September 22, 2021 combined discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 9/23/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg) (Entered: 09/23/2021) |
ORAL ORDER: Having been referred non-party Dr. Roscigno's Motion to Partially Quash Subpoenas (C.A. No. 21-mc-377, D.I. 1), IT IS HEREBY ORDERED that Liquidia and UTC (collectively "the parties") and non-party Dr. Roscigno shall meet and confer regarding whether the subpoena requests can and should be narrowed. The parties and Dr. Roscigno shall file a joint status letter on or before October 1, 2021 that sets forth their respective positions on any issues remaining in dispute. The letter shall not exceed six pages, and shall be in no less than 12-point font. Counsel is reminded to provide courtesy copies. The Court may thereafter order a teleconference. ORDERED by Judge Jennifer L. Hall on 9/23/2021. Associated Cases: 1:21-mc-00377-RGA-JLH, 1:20-cv-00755-RGA-JLH(ceg) (Entered: 09/23/2021) |
ORAL ORDER: The redacted filings (D.I. 189 and 191 ) are REJECTED because parts of them are redacted in their entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 9/28/2021. (nms) (Entered: 09/28/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 197 ). A discovery dispute teleconference is scheduled for October 14, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than October 8, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than October 12, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 10/6/2021. (ceg) (Entered: 10/06/2021) |
ORAL ORDER: The pending Motion for Teleconference to Resolve Protective Order Dispute (D.I. 203 ) will be heard at the currently scheduled October 14, 2021 teleconference. By no later than today, October 12, 2021, at 6:00 pm, the party(ies) seeking relief shall file with the Court a letter, not to exceed two pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than October 13, 2021, at 3:00 pm, any party(ies) opposing the application for relief may file a letter, not to exceed two pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. ORDERED by Judge Jennifer L. Hall on 10/12/2021. (ceg) (Entered: 10/12/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the October 14, 2021 discovery/protective order dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 10/14/2021. (ceg) (Entered: 10/14/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Expert Discovery Dispute (D.I. 219 ). A discovery dispute teleconference is scheduled for November 4, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than November 1, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than November 3, 2021, at 12:00 p.m. Eastern Time, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 10/29/2021. (ceg) (Entered: 10/29/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the November 4, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 11/4/2021. (ceg) (Entered: 11/04/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 232 ). A discovery dispute teleconference is scheduled for November 18, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than November 15, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than November 17, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 11/12/2021. (ceg) (Entered: 11/12/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the November 18, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 11/18/2021. (ceg) (Entered: 11/18/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Dispute (D.I. 250 ). A discovery dispute teleconference is scheduled for December 6, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than December 2, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than December 3, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 12/1/2021. (ceg) (Entered: 12/01/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the December 6, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 12/6/2021. (ceg) (Entered: 12/07/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 259 ). A discovery dispute teleconference is scheduled for December 14, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than December 14, 2021, at 12:00 PM Eastern Time, the parties shall simultaneously file a one page letter brief with no responsive letter briefs. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 12/10/2021. (ceg) (Entered: 12/10/2021) |
ORAL ORDER: Liquidias Motion for Leave to Move for Summary Judgment (D.I. 224 ) is GRANTED-IN-PART and DENIED-IN-PART. The Court grants Liquidia leave to move for summary judgment of invalidity of the 066 patent and 901 patent due to collateral estoppel and denies leave to move for summary judgment of invalidity of the 901 patent as obvious. Liquidias motion and brief are due on January 7, 2022. Ordered by Judge Richard G. Andrews on 12/14/2021. (nms) (Entered: 12/14/2021) |
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the December 14, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 12/14/2021. (ceg) (Entered: 12/14/2021) |
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 301 ). A discovery dispute teleconference is scheduled for February 17, 2022 at 12:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than COB on February 14, 2022, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than noon on February 16, 2022, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 2/11/2022. (ceg) (Entered: 02/11/2022) |
ORAL ORDER: The Motion for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel (D.I. 281 ) is now REFFERED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 2/14/2022. Motions referred to Jennifer L. Hall.(nms) (Entered: 02/14/2022) |
ORAL ORDER: Having reviewed the letters submitted by the parties in connection with the Motion for Teleconference Regarding Discovery Dispute (D.I. 301 , 305 , 306 ), it is ORDERED that Liquidia's request is denied as moot. The teleconference scheduled for February 17, 2022 is CANCELLED. ORDERED by Judge Jennifer L. Hall on 2/16/2022. (ceg) (Entered: 02/16/2022) |
ORAL ORDER: On or before February 23, 2022, counsel should submit to the Clerk's Office (2) courtesy copies of all briefs and (2) copies of any other document filed in support of any briefs (i.e., appendices, exhibits, declarations, affidavits etc.) regarding the pending motion(s) referred to Judge Hall. ORDERED by Judge Jennifer L. Hall on 2/17/2022. (ceg) (Entered: 02/17/2022) |
ORAL ORDER re Motion for Summary Judgment: A hearing on the pending Motion for Summary Judgment (D.I. 281 ) is scheduled for March 10, 2022 at 2:30 PM via video conference before Judge Jennifer L. Hall. Each side will be allocated 15 minutes for argument. The parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information regarding oral argument on or before March 8, 2022: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be presenting argument. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Slide presentations or demonstratives may be presented by the parties on the video conference screen or referred to by the parties at the hearing. Once the dial-in information is received by the Court, members of the public may obtain it by contacting Chambers at Cailah_Garfinkel@ded.uscourts.gov. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. All participants shall be present on the video conference no later than 10 minutes prior to the start of the hearing. The Court may choose to resolve the motion prior to the hearing and will, in that event, cancel the hearing. ORDERED by Judge Jennifer L. Hall on 3/1/2022. (ceg) (Entered: 03/01/2022) |
ORAL ORDER: The Stipulation to Extend Time (D.I. 328 ) is DENIED without prejudice, and the parties are given leave to raise the issue at the Pretrial Conference. Ordered by Judge Richard G. Andrews on 3/2/2022. (nms) (Entered: 03/02/2022) |
ORAL ORDER: The Motion for Summary Judgment hearing will resume telephonically on Friday, March 11, 2022, at 3:00 PM Eastern Time before Judge Jennifer L. Hall. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. ORDERED by Judge Jennifer L. Hall on 3/10/2022. (ceg) (Entered: 03/10/2022) |
ORAL ORDER re REPORT AND RECOMMENDATION: For the reasons announced from the bench at today's teleconference, the Court recommends that the pending motion for summary judgment (D.I. 281 ) be DENIED. The Court anticipates that it will file on the docket a written document incorporating a transcript of its oral recommendation. ORDERED by Judge Jennifer L. Hall on 3/11/2022. (ceg) (Entered: 03/11/2022) |
ORAL ORDER: The redacted filing (D.I. 380 ) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 3/28/2022. (nms) (Entered: 03/28/2022) |
ORAL ORDER: The redaction version of D.I. 344 (D.I. 385 ) as supported by the Declaration (D.I. 386 ) is APPROVED. Ordered by Judge Richard G. Andrews on 4/5/2022. (nms) (Entered: 04/05/2022) |
ORAL ORDER: In the post-trial briefing, the parties dispute whether the treprostinil disclosed in Moriarty can anticipate the claimed pharmaceutical composition[/product] comprising treprostinil. (D.I. 413 at 8-9; D.I. 415 at 1). The Court requests further briefing on this issue. Specifically, the parties should address the following issues: (1) whether the terms pharmaceutical composition (claim 1) and pharmaceutical product (claim 9) carry patentable weight; and (2) whether treprostinil is a pharmaceutical composition[/product] comprising treprostinil. Each party should submit a letter not exceeding four pages by Friday, July 15. Ordered by Judge Richard G. Andrews on 7/12/2022. (nms) (Entered: 07/12/2022) |
ORAL ORDER: Liquidia filed a notice that the PTAB invalidated all claims of the 793 patent. (D.I. 425 ). I request that the parties submit letters of no more than three pages by the COB Monday, August 15, 2022, advising of their positions, with authority, as to whether that decision compels that I treat the 793 patent as being invalid. Ordered by Judge Richard G. Andrews on 8/12/2022. (lak) (Entered: 08/12/2022) |
ORAL ORDER: I request that UTC submits a letter of no more than two pages by the COB Friday, August 26, 2022, responding to Liquidias request that I stay my decision on the 793 patent pending appeal of the PTABs decision. (D.I. 427 at 3). Ordered by Judge Richard G. Andrews on 8/23/2022. (nms) (Entered: 08/23/2022) |
ORAL ORDER: The parties are requested to jointly submit a proposed final judgment no later than September 8, 2022. Ordered by Judge Richard G. Andrews on 8/31/2022. (nms) (Entered: 08/31/2022) |
COMPLAINT for PATENT INFRINGEMENT filed against Liquidia Technologies, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2974028.) - filed by United Therapeutics Corporation. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(nmg) (Entered: 06/05/2020) |
First AMENDED COMPLAINT against Liquidia Technologies, Inc. - filed by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-C)(Blumenfeld, Jack) Modified on 7/27/2020 (nms). (Entered: 07/22/2020) |
PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: # 1 Letter)(Flynn, Michael) Modified on 7/28/2020 (nms). (Entered: 07/28/2020) |
PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: # 1 Letter)(Blumenfeld, Jack) Modified on 7/31/2020 (nms). (Entered: 07/31/2020) |
Joint Letter to The Honorable Richard G. Andrews from Nathan R. Hoeschen and Jack B. Blumenfeld regarding Protective Order. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Hoeschen, Nathan) (Entered: 08/21/2020) |
DECLARATION of Joshua Mack re 28 MOTION to Dismiss Invalidity Counterclaims and Defenses, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-9)(Flynn, Michael) Modified on 8/26/2020 (nms). (Entered: 08/26/2020) |
Joint Claim Construction Chart, Volume 1 of 2, by United Therapeutics Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, part 1, # 4 Exhibit C, part 2)(Flynn, Michael) Modified on 1/8/2021 (nms). (Entered: 01/08/2021) |
Joint Claim Construction Chart, Volume 2 of 2, by United Therapeutics Corporation. (Attachments: # 1 Exhibit C, part 3, # 2 Exhibit C, part 4)(Flynn, Michael) Modified on 1/8/2021 (nms). (Entered: 01/08/2021) |
[SEALED] Joint Appendix, Volume 1 of 4 re 75 Joint Claim Construction Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-2, P1-P6)(Flynn, Michael) Modified on 5/3/2021 (nms). (Attachment 1 replaced on 6/1/2021) (nms). (Entered: 04/30/2021) |
[SEALED] Joint Appendix, Volume 2 of 4 re 75 Joint Claim Construction Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D1-D7)(Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
[SEALED] Joint Appendix, Volume 3 of 4 re 75 Joint Claim Construction Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D8-D20)(Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
[SEALED] Joint Appendix, Volume 4 of 4 re 75 Joint Claim Construction Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D21-29, # 2 Exhibits D30-33)(Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Hoeschen, Nathan) (Entered: 05/05/2021) |
REDACTED VERSION of 76 Appendix, Volume 1 of 4, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-2, P1-P6)(Flynn, Michael) Modified on 5/13/2021 (nms). (Entered: 05/13/2021) |
REDACTED VERSION of 77 Appendix, Volume 2 of 4, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D1-D7)(Flynn, Michael) Modified on 5/13/2021 (nms). (Entered: 05/13/2021) |
REDACTED VERSION of 78 Appendix, Volume 3 of 4, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D8-D20)(Flynn, Michael) Modified on 5/13/2021 (nms). (Entered: 05/13/2021) |
REDACTED VERSION of 79 Appendix, Volume 4 of 4, by United Therapeutics Corporation. (Attachments: # 1 Exhibits D21-29, # 2 Exhibits D30-33)(Flynn, Michael) Modified on 5/13/2021 (nms). (Entered: 05/13/2021) |
[SEALED] RESPONSE to 81 MOTION for Issuance of a Letter of Request for International Judicial Assistance, filed by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Hoeschen, Nathan) Modified on 5/14/2021 (nms). (Entered: 05/14/2021) |
[SEALED] REPLY BRIEF re 81 MOTION for Issuance of a Letter of Request for International Judicial Assistance filed by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-7)(Flynn, Michael) (Main Document 99 replaced on 5/24/2021) (nms). (Entered: 05/21/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Hoeschen, Nathan) (Entered: 05/28/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding Liquidia's May 28 letter (D.I. 105 ). (Attachments: # 1 Exhibits A-C)(Flynn, Michael) Modified on 6/4/2021 (nms). (Entered: 06/03/2021) |
MOTION for Leave to File a Second Amended Complaint - filed by United Therapeutics Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Flynn, Michael) Modified on 6/7/2021 (nms). (Entered: 06/04/2021) |
[SEALED] OPENING BRIEF in Support re 109 MOTION for Leave to File a Second Amended Complaint, filed by United Therapeutics Corporation.Answering Brief/Response due date per Local Rules is 6/18/2021. (Attachments: # 1 Exhibits A-L)(Flynn, Michael) Modified on 6/7/2021 (nms). (Entered: 06/04/2021) |
REDACTED VERSION of 106 Letter, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-C)(Flynn, Michael) Modified on 6/11/2021 (nms). (Entered: 06/10/2021) |
REDACTED VERSION of 110 Opening Brief in Support, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-L)(Flynn, Michael) Modified on 6/16/2021 (nms). (Entered: 06/15/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding Motion for Issuance of a Letter of Request for International Judicial Assistance (D.I. 81 ). (Attachments: # 1 Exhibits A-C)(Flynn, Michael) Modified on 6/18/2021 (nms). (Entered: 06/17/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Karen E. Keller. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Keller, Karen) (Entered: 06/17/2021) |
JOINT Submission Regarding Remaining Terms for Claim Construction, filed by United Therapeutics Corporation. (Attachments: # 1 Exhibits J1-J8)(Flynn, Michael) Modified on 6/22/2021 (nms). (Entered: 06/21/2021) |
REDACTED VERSION of 120 Letter, by United Therapeutics Corporation. (Attachments: # 1 Exhibit A-C)(Flynn, Michael) (Entered: 06/24/2021) |
[SEALED] ANSWERING BRIEF in Opposition re 109 MOTION for Leave to File a Second Amended Complaint filed by Liquidia Technologies, Inc..Reply Brief due date per Local Rules is 7/8/2021. (Attachments: # 1 Appendix 1, # 2 Appendix 2, # 3 Appendix 3, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 16)(Keller, Karen) (Entered: 07/01/2021) |
[SEALED] Request for Judicial Notice in support of its Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 5, # 4 Exhibit 6, # 5 Exhibit 7, # 6 Exhibit 8, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 13)(Keller, Karen) Modified on 7/1/2021 (nms). (Entered: 07/01/2021) |
[SEALED] REPLY BRIEF re 109 MOTION for Leave to File a Second Amended Complaint filed by United Therapeutics Corporation. (Attachments: # 1 Exhibit E, # 2 Exhibit M)(Flynn, Michael) (Entered: 07/12/2021) |
REDACTED VERSION of 135 Reply Brief by United Therapeutics Corporation. (Attachments: # 1 Exhibit E, # 2 Exhibit M)(Flynn, Michael) (Entered: 07/20/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Non-Party LGM Pharma, LLC's Motion to Quash. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hoeschen, Nathan) (Entered: 09/16/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Discovery Disputes. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Hoeschen, Nathan) (Entered: 09/16/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Michael Flynn regarding Discovery Dispute. (Attachments: # 1 Exs. A-D)(Flynn, Michael) (Entered: 09/16/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding re: Discovery Disputes. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Hoeschen, Nathan) (Entered: 09/20/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding Discovery Dispute. (Attachments: # 1 Exhibits A-E)(Flynn, Michael) Modified on 9/21/2021 (nms). (Entered: 09/20/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding response to LGM Pharma, LLC's Motion to Quash Letter (D.I. 177]). (Attachments: # 1 Exhibits A-E)(Flynn, Michael) Modified on 9/21/2021 (nms). (Entered: 09/20/2021) |
REDACTED VERSION of 179 Letter by United Therapeutics Corporation. (Attachments: # 1 Exhibit A-D)(Flynn, Michael) (Entered: 09/24/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding Discovery Dispute. (Attachments: # 1 Exhibits A-B)(Flynn, Michael) Modified on 10/8/2021 (nms). (Entered: 10/08/2021) |
NOTICE of Supplemental Authority by Liquidia Technologies, Inc. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 10/12/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding response to Plaintiff's October 8, 2021 discovery dispute letter (D.I. 201 ). (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) Modified on 10/12/2021 (nms). (Entered: 10/12/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding protective order dispute. (Attachments: # 1 Exhibits 1-15, part 1, # 2 Exhibits 1-15, part 2, # 3 Exhibits 1-15, part 3)(Flynn, Michael) Modified on 10/13/2021 (nms). (Entered: 10/12/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding response to Plaintiff's October 12, 2021 discovery dispute letter (D.I. 207 ). (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Hoeschen, Nathan) Modified on 10/13/2021 (nms). (Main Document 208 replaced on 10/13/2021) (ceg). (Entered: 10/13/2021) |
REDACTED VERSION of 207 Letter, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-11, # 2 Exhibits 12-15)(Flynn, Michael) Modified on 10/22/2021 (nms). (Entered: 10/22/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Michael J. Flynn regarding 35 U.S.C § 315 and Objections to Liquidia's Expert Reports. (Attachments: # 1 Exhibits 1-3)(Flynn, Michael) (Entered: 11/01/2021) |
MOTION for Leave to Move for Summary Judgment - filed by Liquidia Technologies, Inc.. (Attachments: # 1 Proposed Order)(Hoeschen, Nathan) Modified on 11/2/2021 (nms). (Entered: 11/02/2021) |
[SEALED] OPENING BRIEF in Support re 224 MOTION for Leave to Move for Summary Judgment, filed by Liquidia Technologies, Inc..Answering Brief/Response due date per Local Rules is 11/16/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11)(Hoeschen, Nathan) Modified on 11/2/2021 (nms). (Entered: 11/02/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Response to Plaintiff's November 1, 2021 Letter regarding 35 U.S.C § 315 and Objections to Liquidia's Expert Reports. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Hoeschen, Nathan) (Entered: 11/03/2021) |
REDACTED VERSION of 222 Letter by United Therapeutics Corporation. (Attachments: # 1 Exhibit 1-3)(Simonetti, Sarah) (Entered: 11/09/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding discovery dispute. (Attachments: # 1 Exhibits A-C)(Flynn, Michael) Modified on 11/16/2021 (nms). (Entered: 11/15/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding response to Plaintiff's November 15th discovery dispute letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Hoeschen, Nathan) (Entered: 11/17/2021) |
[SEALED] ANSWERING BRIEF in Opposition re 224 MOTION for Leave to Move for Summary Judgment filed by United Therapeutics Corporation.Reply Brief due date per Local Rules is 11/30/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Flynn, Michael) (Entered: 11/23/2021) |
REDACTED VERSION of 235 Letter by United Therapeutics Corporation. (Attachments: # 1 Exhibit A-C)(Flynn, Michael) (Entered: 11/23/2021) |
REDACTED VERSION of 246 Answering Brief in Opposition, by United Therapeutics Corporation. (Attachments: # 1 Exhibit 1-5)(Simonetti, Sarah) (Entered: 12/01/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N)(Hoeschen, Nathan) Modified on 12/3/2021 (nms). (Entered: 12/02/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding response to Liquidia's December 2, 2021 letter (D.I. 254 ). (Attachments: # 1 Exhibits 1-6)(Flynn, Michael) Modified on 12/6/2021 (nms). (Entered: 12/03/2021) |
[SEALED] REPLY BRIEF re 224 MOTION for Leave to Move for Summary Judgment filed by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 12, # 2 Exhibit 13, # 3 Exhibit 14, # 4 Exhibit 15)(Hoeschen, Nathan) (Entered: 12/07/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Hoeschen, Nathan) Modified on 12/14/2021 (ceg). (Entered: 12/14/2021) |
Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding scope of the deposition of Dr. Seeger. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Flynn, Michael) (Entered: 12/14/2021) |
REDACTED VERSION of 255 Letter by United Therapeutics Corporation. (Attachments: # 1 Exhibit 1-6)(Simonetti, Sarah) (Entered: 12/16/2021) |
MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel - filed by Liquidia Technologies, Inc.. (Attachments: # 1 Proposed Order)(Keller, Karen) Modified on 1/7/2022 (nms). (Entered: 01/07/2022) |
[SEALED] OPENING BRIEF in Support re 281 MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel, filed by Liquidia Technologies, Inc..Answering Brief/Response due date per Local Rules is 1/21/2022. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32)(Keller, Karen) Modified on 1/7/2022 (nms). (Entered: 01/07/2022) |
[SEALED] DECLARATION of Michael Flynn re 290 Answering Brief in Opposition, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-14)(Flynn, Michael) Modified on 1/31/2022 (nms). (Entered: 01/28/2022) |
REDACTED VERSION of 293 Declaration by United Therapeutics Corporation. (Attachments: # 1 Exhibit 1-14)(Simonetti, Sarah) (Entered: 02/04/2022) |
[SEALED] REPLY BRIEF re 281 MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel filed by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 33, # 2 Exhibit 34, # 3 Exhibit 35, # 4 Exhibit 36, # 5 Exhibit 37, # 6 Exhibit 38, # 7 Exhibit 39, # 8 Exhibit 40, # 9 Exhibit 41, # 10 Exhibit 42, # 11 Exhibit 43)(Hoeschen, Nathan) (Additional attachment(s) added on 2/14/2022: # 12 Exhibit 44) (nms). (Attachment 1 replaced on 2/23/2022) (nms). (Attachment 9 replaced on 2/23/2022) (nms). (Attachment 10 replaced on 2/23/2022) (nms). (Attachment 11 replaced on 2/23/2022) (nms). (Entered: 02/11/2022) |
[SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Defendant's Opening Discovery Dispute Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Hoeschen, Nathan) (Entered: 02/14/2022) |
[SEALED] DECLARATION of Michael J. Flynn re 312 Opening Brief in Support, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-Z)(Flynn, Michael) Modified on 2/23/2022 (nms). (Entered: 02/22/2022) |
[SEALED] DECLARATION of F. Dean Toste re 312 Opening Brief in Support, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-7)(Flynn, Michael) Modified on 2/23/2022 (nms). (Entered: 02/22/2022) |
[SEALED] Proposed Joint Pretrial Order, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-16)(Flynn, Michael) Modified on 3/1/2022 (nms). (Attachment 1 replaced on 3/1/2022) (nms). (Entered: 02/28/2022) |
[SEALED] EXHIBITS to 323 MOTION in Limine No. 1, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-D, # 2Exhibits 1-10)(Flynn, Michael) Modified on 3/1/2022 (nms). (Entered: 02/28/2022) |
[SEALED] EXHIBITS to 325 MOTION in Limine No. 2, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-L, # 2 Exhibits 1-5)(Flynn, Michael) Modified on 3/1/2022 (nms). (Entered: 02/28/2022) |
[SEALED] EXHIBITS to 320 MOTION in Limine to Exclude Portions of Dr. Mahdi Fawzi's Rebuttal Expert Report, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibits 1-8, # 2 Exhibits A-H)(Hoeschen, Nathan) Modified on 3/3/2022 (nms). (Entered: 03/03/2022) |
[SEALED] Amended Exhibits to 322 Proposed Pretrial Order, by United Therapeutics Corporation. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11)(Simonetti, Sarah) Modified on 3/4/2022 (nms). (Entered: 03/03/2022) |
REDACTED VERSION of 313 Declaration by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-Z)(Simonetti, Sarah) (Entered: 03/08/2022) |
REDACTED VERSION of 314 Declaration by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-7)(Simonetti, Sarah) (Entered: 03/08/2022) |
[SEALED] DECLARATION of Douglas Cheek Volume 1 of 2 re 343 Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Hoeschen, Nathan) Modified on 3/9/2022 (nms). (Entered: 03/08/2022) |
[SEALED] DECLARATION of Douglas Cheek Volume 2 of 2 re 343 Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 5, # 4 Exhibit 6, # 5 Exhibit 7, # 6 Exhibit 8, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 13, # 12 Exhibit 14, # 13 Exhibit 15, # 14 Exhibit 16, # 15 Exhibit 17, # 16 Exhibit 18, # 17 Exhibit 19, # 18 Exhibit 20, # 19 Exhibit 21, # 20 Exhibit 22, # 21 Exhibit 23, # 22 Exhibit 24, # 23 Exhibit 25, # 24 Exhibit 26, # 25 Exhibit 27, # 26 Exhibit 28, # 27 Exhibit 29, # 28 Exhibit 30, # 29 Exhibit 31, # 30 Exhibit 32, # 31 Exhibit 33, # 32 Exhibit 34, # 33 Exhibit 35, # 34 Exhibit 36, # 35 Exhibit 37, # 36 Exhibit 38, # 37 Exhibit 39, # 38 Exhibit 40, # 39 Exhibit 41, # 40 Exhibit 42, # 41 Exhibit 43, # 42 Exhibit 44, # 43 Exhibit 45, # 44 Exhibit 46, # 45 Exhibit 47, # 46 Exhibit 48, # 47 Exhibit 49, # 48 Exhibit 50, # 49 Exhibit 51)(Hoeschen, Nathan) Modified on 3/9/2022 (nms). (Entered: 03/08/2022) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding question posed by the Court at the hearing on Liquidia's Motion for Summary Judgment. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Hoeschen, Nathan) Modified on 3/11/2022 (nms). (Entered: 03/10/2022) |
[SEALED] DECLARATION of Michael J. Flynn re 352 Reply Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits AA-LL, part 1, # 2 Exhibits AA-LL, part 2, # 3 Exhibits AA-LL, part 3)(Flynn, Michael) Modified on 3/15/2022 (nms). (Entered: 03/14/2022) |
REDACTED VERSION of 333 Exhibit to a Document by United Therapeutics Corporation. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11)(Simonetti, Sarah) (Entered: 03/18/2022) |
REDACTED VERSION of 326 Exhibit to a Document by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-L, # 2 Exhibits 1-5)(Simonetti, Sarah) (Entered: 03/18/2022) |
REDACTED VERSION of 353 Declaration of Michael J. Flynn, by United Therapeutics Corporation. (Attachments: # 1 Exhibits AA-LL, part 1, # 2 Exhibits AA-LL, part 2, # 3 Exhibits AA-LL, part 3)(Simonetti, Sarah) Modified on 3/22/2022 (nms). (Entered: 03/21/2022) |
REDACTED VERSION of 324 Sealed Exhibits, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-D, # 2 Exhibits 1-10)(Simonetti, Sarah) Modified on 3/22/2022 (nms). (Entered: 03/22/2022) |
NOTICE of Lodging of Plaintiff`s Trial Demonstratives by United Therapeutics Corporation (Attachments: # 1 Exhibits 1-10)(Flynn, Michael) (Entered: 04/07/2022) |
NOTICE of Lodging of Defendant`s Trial Demonstratives by Liquidia Technologies, Inc. (Attachments: # 1 Exhibts 1-6)(Hoeschen, Nathan) (Entered: 04/07/2022) |
DECLARATION of Michael J. Flynn re 397 Response to Objections, by United Therapeutics Corporation. (Attachments: # 1 Exhibit A)(Flynn, Michael) Modified on 4/14/2022 (nms). (Entered: 04/13/2022) |
Letter to Honorable Richard G. Andrews from Nathan R. Hoeschen regarding Drug Master File Exhibits. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Hoeschen, Nathan) (Entered: 06/30/2022) |
Letter to The Honorable Richard G. Andrews, from Michael Flynn responding to Liquidia`s June 30, 2022, letter (D.I. 419 ). (Attachments: # 1 Exhibit 1)(Flynn, Michael) Modified on 7/7/2022 (nms). (Entered: 07/07/2022) |
Letter to The Honorable Judge Richard G. Andrews, from Nathan R. Hoeschen, regarding dispute whether the treprostinil disclosed in Moriarty can anticipate the claimed pharmaceutical composition[product] comprising treprostinil. (Attachments: # 1 JTX2, # 2 Trial Transcript Excerpts, # 3 DTX258)(Hoeschen, Nathan) Modified on 7/18/2022 (nms). (Entered: 07/15/2022) |
Letter to The Honorable Richard G. Andrews, from Michael J. Flynn, regarding discovery dispute. (Attachments: # 1 Exhibits A-B)(Flynn, Michael) Modified on 7/18/2022 (nms). (Entered: 07/15/2022) |
NOTICE of Subsequent Authority by Liquidia Technologies, Inc. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 07/19/2022) |
Letter to The Honorable Richard G. Andrews, from Michael Flynn, regarding the Court`s August 12, 2022 (D.I. 426 ). (Attachments: # 1 Exhibits A-D)(Flynn, Michael) Modified on 8/16/2022 (nms). (Entered: 08/15/2022) |
PROPOSED Final Judgment, by United Therapeutics Corporation. (Attachments: # 1 Letter)(Flynn, Michael) Modified on 9/9/2022 (nms). (Entered: 09/08/2022) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,593,066 B2; 9,604,901 B2; 10,716,793 B2. (Attachments: # 1 Final Judgment)(nms) (Entered: 09/09/2022) |
MOTION to Stay Enforcement of Paragraph 4 of the Court`s Final Judgment Pending Appeal - filed by Liquidia Technologies, Inc.. (Attachments: # 1 Proposed Order)(Hoeschen, Nathan) Modified on 9/9/2022 (nms). (Entered: 09/09/2022) |
OPENING BRIEF in Support re 438 MOTION to Stay Enforcement of Paragraph 4 of the Court`s Final Judgment Pending Appeal, filed by Liquidia Technologies, Inc..Answering Brief/Response due date per Local Rules is 9/23/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X, # 25 Exhibit Y, # 26 Exhibit Z)(Hoeschen, Nathan) Modified on 9/9/2022 (nms). (Entered: 09/09/2022) |
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 06/05/2020) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/27/2020. Date of Expiration of Patent: 12/15/2028.Thirty Month Stay Deadline: 10/27/2022. (nmg) (Entered: 06/05/2020) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,593,066 B2; 9,604,901 B2. (nmg) (Entered: 06/05/2020) |
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock Inc. for United Therapeutics Corporation filed by United Therapeutics Corporation. (nmg) (Entered: 06/05/2020) |
Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) (Entered: 06/05/2020) |
SUMMONS Returned Executed by United Therapeutics Corporation. Liquidia Technologies, Inc. served on 6/5/2020, answer due 6/26/2020. (Blumenfeld, Jack) (Entered: 06/05/2020) |
MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/11/2020 (nms). (Entered: 06/11/2020) |
MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 06/11/2020) |
STIPULATION and Order to Extend Time - filed by Liquidia Technologies, Inc.. (Fry, David) Modified on 6/26/2020 (nms). (Entered: 06/25/2020) |
ANSWER to 1 Complaint, and COUNTERCLAIM against United Therapeutics Corporation by Liquidia Technologies, Inc..(Keller, Karen) Modified on 7/17/2020 (nms). (Entered: 07/16/2020) |
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 07/16/2020) |
MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan - filed by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 07/16/2020) |
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 7/30/2020, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/21/2020. (nms) (Entered: 07/21/2020) |
Letter to The Honorable Richard G. Andrews, from Jack Blumenfeld, regarding dial-in information for the July 30, 2020 scheduling teleconference. (Blumenfeld, Jack) Modified on 7/21/2020 (nms). (Entered: 07/21/2020) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,793 . (Blumenfeld, Jack) (Entered: 07/22/2020) |
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery. Joinder of Parties due by 6/4/2021. Amended Pleadings due by 6/4/2021. Fact Discovery completed by 9/17/2021. Dispositive Motions due by 11/2/2021. Joint Claim Construction Brief due by 4/30/2021. A Markman Hearing is set for 5/24/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/4/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set for 3/28/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/31/2020. (nms) (Entered: 07/31/2020) |
NOTICE OF SERVICE of Defendants First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-80) filed by Liquidia Technologies, Inc..(Castellano, Jeffrey) (Entered: 08/04/2020) |
Official Transcript of Scheduling Conference held on 7/30/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/26/2020. Redacted Transcript Deadline set for 9/8/2020. Release of Transcript Restriction set for 11/3/2020. (Triozzi, Heather) (Entered: 08/05/2020) |
ANSWER to 16 Amended Complaint, COUNTERCLAIMS and Affirmative Defenses against United Therapeutics Corporation, by Liquidia Technologies, Inc..(Castellano, Jeffrey) Modified on 8/5/2020 (nms). (Entered: 08/05/2020) |
STIPULATION TO EXTEND TIME to submit a Protective Order to August 14, 2020 - filed by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 08/10/2020) |
NOTICE OF SERVICE of Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by United Therapeutics Corporation.(Blumenfeld, Jack) (Entered: 08/14/2020) |
ORDER ON PROTECTIVE ORDER DISPUTE (see Order for further details). Signed by Judge Richard G. Andrews on 8/25/2020. (nms) (Entered: 08/25/2020) |
MOTION to Dismiss Invalidity Counterclaims and Defenses - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/26/2020 (nms). (Entered: 08/26/2020) |
OPENING BRIEF in Support re 28 MOTION to Dismiss Invalidity Counterclaims and Defenses, filed by United Therapeutics Corporation.Answering Brief/Response due date per Local Rules is 9/9/2020. (Flynn, Michael) Modified on 8/26/2020 (nms). (Entered: 08/26/2020) |
Request for Judicial Notice in Support of Motion to Dismiss Defendant's Counterclaim, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/26/2020 (nms). (Entered: 08/26/2020) |
PROPOSED Stipulated Protective Order, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 8/28/2020 (nms). (Entered: 08/28/2020) |
SO ORDERED Granting 32 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/28/2020. (nms) (Entered: 08/31/2020) |
NOTICE OF SERVICE of Defendants Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/31/2020) |
NOTICE OF SERVICE of (1) United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 4 of the District of Delaware Default Standard for Discovery and (2) United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/31/2020) |
NOTICE OF SERVICE of Responses and Objections to Liquidia's First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-80) filed by United Therapeutics Corporation.(Blumenfeld, Jack) (Entered: 09/03/2020) |
ANSWERING BRIEF in Opposition re 28 MOTION to Dismiss Invalidity Counterclaims and Defenses filed by Liquidia Technologies, Inc..Reply Brief due date per Local Rules is 9/16/2020. (Hoeschen, Nathan) (Entered: 09/09/2020) |
REPLY BRIEF re 28 MOTION to Dismiss Invalidity Counterclaims and Defenses filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 09/16/2020) |
NOTICE OF SERVICE of Plaintiff's First Set of Requests for Production of Documents to Liquidia Technologies, Inc. (1-67) filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 10/01/2020) |
NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Preliminary Infringement Contentions - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 10/16/2020) |
NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's First Set of Interrogatories to Liquidia Technologies, Inc. (No. 1) filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 10/22/2020) |
MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 10/26/2020) |
ORDER Setting Teleconference: A Telephone Conference is set for 12/11/2020 at 12:30 PM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Plaintiffs' counsel to initiate the call. Signed by Judge Mary Pat Thynge on 10/30/20. (cak) (Entered: 10/30/2020) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's First Set of Requests for the Production of Documents (1-67) filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 11/02/2020) |
MEMORANDUM ORDER: The Motion to Dismiss Invalidity Counterclaims and Defenses (D.I. 28 ) is DENIED. Signed by Judge Richard G. Andrews on 11/3/2020. (nms) (Entered: 11/03/2020) |
MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 11/03/2020) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Preliminary Invalidity Contentions filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 11/13/2020) |
ANSWER to 23 Answer to Amended Complaint, and Counterclaim, by United Therapeutics Corporation.(Flynn, Michael) Modified on 11/17/2020 (nms). (Entered: 11/17/2020) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-7) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 11/17/2020) |
NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories (No. 1) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 11/23/2020) |
NOTICE OF SERVICE of Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-7) filed by United Therapeutics Corporation.(Blumenfeld, Jack) (Entered: 12/17/2020) |
NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Opening Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901, (2) Declaration of Joshua Mack in Support of Plaintiff United Therapeutics Corporation's Opening Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901 and (3) Declaration of Robert R. Ruffolo, Ph.D. - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 02/05/2021) |
NOTICE to Take Deposition of Robert R. Ruffolo on February 17, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 02/08/2021) |
NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Second Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 2-10) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 03/04/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.s Second Set of Interrogatories to Plaintiff (Nos. 8-13) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 03/18/2021) |
AMENDED Notice to Take Deposition of Robert R. Ruffolo on April 15, 2021 at 9:00 a.m. EST, filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) Modified on 3/30/2021 (nms). (Entered: 03/29/2021) |
NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production of Documents to Liquidia Technologies, Inc. (68-77) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 03/29/2021) |
NOTICE of Change of Firm Affiliation by United Therapeutics Corporation (Blumenfeld, Jack) (Entered: 04/02/2021) |
NOTICE requesting Clerk to remove Joshua Mack as co-counsel. Reason for request: no longer with firm. (Blumenfeld, Jack) (Entered: 04/02/2021) |
NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Reply Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901 and (2) Supplemental Declaration of Robert R. Ruffolo, Ph.D. - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/02/2021) |
NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 2-10) filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 04/05/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Bill Ward - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 04/07/2021) |
STIPULATION to Amend Protective Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/13/2021 (nms). (Entered: 04/12/2021) |
SO ORDERED Granting 65 Stipulation to Amend Protective Order. Signed by Judge Richard G. Andrews on 4/13/2021. (nms) (Entered: 04/13/2021) |
NOTICE OF SERVICE of Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 8-13) filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/19/2021) |
NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Third Set of Interrogatories to Plaintiff (No. 14) filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 04/26/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's Second Set of Requests for Production of Documents (68-77) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 04/28/2021) |
NOTICE OF SERVICE of Defendant's Amended Disclosures Under Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 04/29/2021) |
MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan) (Entered: 04/29/2021) |
JOINT Claim Construction Brief, filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
Joint Motion for Claim Construction - filed by United Therapeutics Corporation.(Flynn, Michael) Modified on 5/3/2021 (nms). Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
MOTION for Issuance of a Letter of Request for International Judicial Assistance - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
[SEALED] MEMORANDUM in Support re 81 MOTION for Issuance of a Letter of Request for International Judicial Assistance, filed by United Therapeutics Corporation.Answering Brief/Response due date per Local Rules is 5/14/2021. (Flynn, Michael) Modified on 5/3/2021 (nms). (Entered: 04/30/2021) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding responding to Liquidia's May 5, 2021 letter (D.I. 84 ). (Flynn, Michael) Modified on 5/12/2021 (nms). (Entered: 05/11/2021) |
REDACTED VERSION of 84 Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 05/12/2021) |
REDACTED VERSION of 82 MEMORANDUM in Support, by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/14/2021) |
NOTICE of Change of Firm Affiliation by United Therapeutics Corporation (Flynn, Michael) (Entered: 05/14/2021) |
REDACTED VERSION of 86 Letter by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/19/2021) |
REDACTED VERSION of 94 Response to Motion, by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 05/21/2021) |
MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Keller, Karen) (Entered: 05/21/2021) |
NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Third Set of Interrogatories (No. 14) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 05/24/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Joshua Revilla, Jiaxiao Zhang, Katherine Pappas and Timothy Dunker of MCDERMOTT WILL & EMERY LLP - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/26/2021) |
REDACTED VERSION of 99 Reply Brief, by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/28/2021) |
REDACTED VERSION of 105 Letter by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 06/04/2021) |
STIPULATION to Extend Time - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/14/2021 (nms). (Entered: 06/11/2021) |
PROPOSED Claim Construction Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/15/2021 (nms). (Entered: 06/15/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Brittany Cazakoff - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 06/16/2021) |
SO ORDERED Granting 117 Proposed Claim Construction Order. Signed by Judge Richard G. Andrews on 6/16/2021. (nms) (Entered: 06/16/2021) |
STIPULATION TO EXTEND TIME for the parties to file their joint supplemental claim construction brief to June 21, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 06/18/2021) |
ORDER: IT IS HEREBY ORDERED that the Motion for Issuance of a Letter of Request for International Judicial Assistance is GRANTED (D.I. 81 ). Signed by Judge Jennifer L. Hall on 6/21/2021. (ceg) (Entered: 06/21/2021) |
REDACTED VERSION of 121 Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 06/24/2021) |
NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Third Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 11-12) filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 07/01/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Fourth Set of Interrogatories to Plaintiff (Nos. 15-16) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 07/02/2021) |
STIPULATION to Extend Time - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 7/6/2021 (nms). (Entered: 07/06/2021) |
REDACTED VERSION of 128 Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 07/08/2021) |
REDACTED VERSION of 129 Exhibit to a Document, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 07/08/2021) |
Letter to The Honorable Jennifer L. Hall, from Michael Flynn regarding assistance with Hague request (D.I. 123 ). (Flynn, Michael) Modified on 7/13/2021 (nms). (Entered: 07/13/2021) |
NOTICE of Subpoenas to Globepharm Consulting, Inc., by United Therapeutics Corporation. (Flynn, Michael) Modified on 7/19/2021 (nms). (Entered: 07/16/2021) |
NOTICE of Subpoenas to LGM Pharma, LLC, by United Therapeutics Corporation (Flynn, Michael) Modified on 7/19/2021 (nms). (Entered: 07/16/2021) |
NOTICE of Subpoenas on Dr. Robert Roscigno, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/2/2021 (nms). (Entered: 08/02/2021) |
NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Fourth Set of Interrogatories (Nos. 15-16) filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/02/2021) |
NOTICE to Take Deposition of Sudersan Tuladhar on August 25, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/04/2021) |
NOTICE to Take Deposition of Raju Penmasta on August 26, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/04/2021) |
NOTICE to Take Deposition of Horst Olschewski on August 23, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/04/2021) |
NOTICE to Take Deposition of Hitesh Batra on September 9, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/04/2021) |
NOTICE to Take Deposition of David Walsh on September 10, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/04/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Rule 30(b)(6) Notice of Deposition of United Therapeutics Corporation filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/06/2021) |
NOTICE of Change of Firm Affiliation for William C. Jackson by United Therapeutics Corporation (Flynn, Michael) (Entered: 08/09/2021) |
NOTICE to Take Deposition of Marisa Law on August 31, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/09/2021) |
NOTICE to Take Deposition of Dr. Benjamin Maynor on September 1, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/09/2021) |
NOTICE to Take Deposition of Jeffrey Kindig on September 2, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/09/2021) |
NOTICE to Take Deposition of Kelli Collin on September 3, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/09/2021) |
Stipulated Amendment to the Protective Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/11/2021 (nms). (Entered: 08/11/2021) |
NOTICE of Subpoenas as to Lewis J. Rubin by Liquidia Technologies, Inc. (Hoeschen, Nathan) (Entered: 08/11/2021) |
SO ORDERED Granting 154 Stipulated Amendment to the Protective Order. Signed by Judge Richard G. Andrews on 8/11/2021. (nms) (Entered: 08/11/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Fifth Set of Interrogatories to Plaintiff (Nos. 17-19) filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 08/13/2021) |
NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 13-14) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/16/2021) |
NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff United Therapeutics Corporation's Third Set of Interrogatories (Nos. 11-12) 2. Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 81-82) 3. Defendant Liquidia Technologies, Inc.'s Sixth Set of Interrogatories to Plaintiff (Nos. 20-21) 4. Defendant Liquidia Technologies, Inc.'s First Set of Requests for Admissions to Plaintiff United Therapeutics Corporation (Nos. 1-14) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 08/16/2021) |
Official Transcript of Markman Hearing held on 6/4/21 before Judge Richard G. Andrews. Court Reporter Patrick O'Hare,Email: rebecca.laurenzi@lexitaslegal.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/8/2021. Redacted Transcript Deadline set for 9/20/2021. Release of Transcript Restriction set for 11/16/2021. (Triozzi, Heather) (Entered: 08/18/2021) |
[SEALED] NOTICE to Take Deposition of Liquidia Technologies, Inc. on a date and a time and location to be agreed upon by counsel filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/18/2021) |
NOTICE OF SERVICE of Plaintiff's Third Set of Requests for Production of Documents to Liquidia Technologies, Inc. (78-88) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/18/2021) |
NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 15-20) and (2) Plaintiff's Requests for Admission to Liquidia Technologies, Inc. (Set 1) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/18/2021) |
REDACTED VERSION of 162 Notice to Take Deposition by United Therapeutics Corporation. (Flynn, Michael) (Entered: 08/26/2021) |
NOTICE OF SERVICE of United Therapeutics Corporation's Responses and Objections to Liquidia Technologies, Inc.'s Rule 30(B)(6) Notice of Deposition - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 08/30/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff United Therapeutics Corporation's Notice of 30(b)(6) Deposition filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 08/31/2021) |
NOTICE to Take Deposition of Dr. Robert Roscigno on September 17, 2021 filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 09/03/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Huiya Wu, Joel Broussard and Harrison Gunn - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 09/07/2021) |
Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 9/13/2021 (ceg). (Entered: 09/13/2021) |
NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Fifth Set of Interrogatories (Nos. 17-19) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 09/13/2021) |
NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Responses to Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories (Nos. 13-14) (2) Defendant Liquidia Technologies, Inc.'s Responses to Plaintiff United Therapeutics Corporation's Fourth [Sic-Fifth] Set of Interrogatories (Nos. 15-20) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 09/14/2021) |
NOTICE OF SERVICE of (1) Plaintiff's Responses and Objections to Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 81-82), (2) Plaintiff's Responses and Objections to Defendant's First Set of Requests for Admission to Plaintiff (Nos. 1-14) and (3) United Therapeutics Corporation's Objections and Responses to Defendant's Sixth Set of Interrogatories (Nos. 20-21) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 09/15/2021) |
NOTICE to Take Deposition of Patrick Poisson on October 5, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 09/15/2021) |
NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's First Set of Requests for Admissions (Nos. 1-20) 2. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's Third Set of Requests for Production of Documents (Nos. 78-88) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 09/16/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Amy Mahan - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 09/22/2021) |
REDACTED VERSION of 177 Letter, by LGM Pharma, LLC, Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 9/24/2021 (nms). (Entered: 09/23/2021) |
REDACTED VERSION of 178 Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 09/23/2021) |
REDACTED VERSION of 180 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 09/27/2021) |
REDACTED VERSION of 181 Letter - by United Therapeutics Corporation. (Flynn, Michael) (Entered: 09/27/2021) |
REDACTED VERSION of 182 Letter, by United Therapeutics Corporation. (Flynn, Michael) Modified on 9/28/2021 (nms). (Entered: 09/27/2021) |
NOTICE OF SERVICE of (1) United Therapeutics Corporation's Supplemental Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 8-13) and Fourth Set of Interrogatories (Nos. 15-16), (2) United Therapeutics Corporation's Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-7) and (3) Plaintiff United Therapeutics Corporation's Supplemental Infringement Contentions - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 09/28/2021) |
NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s First Supplemental Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 2-10) 2. Defendant Liquidia Technologies, Inc.'s First Supplemental Invalidity Contentions filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 09/29/2021) |
STIPULATION to Extend Time to file a joint status letter pursuant to the Court's order to October 8, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 10/01/2021) |
NOTICE to Take Deposition of Todd Battistoni on October 7, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 10/04/2021) |
MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) (Entered: 10/04/2021) |
REDACTED VERSION of 182 Letter, by United Therapeutics Corporation. (Flynn, Michael) Modified on 10/5/2021 (nms). (Entered: 10/05/2021) |
REDACTED VERSION of 180 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Main Document 199 replaced on 10/6/2021) (ceg). (Entered: 10/05/2021) |
[SEALED] Joint Letter to Hon. Jennifer L. Hall, from Nathan Hoeschen, regarding the subpoenas served on Dr. Roscigno. (Hoeschen, Nathan) Modified on 10/12/2021 (nms). (Entered: 10/08/2021) |
MOTION for Teleconference to Resolve Protective Order Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 10/12/2021 (nms). (Entered: 10/12/2021) |
REDACTED VERSION of 201 Letter by United Therapeutics Corporation. (Flynn, Michael) (Entered: 10/14/2021) |
REDACTED VERSION of 202 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 10/15/2021 (nms). (Entered: 10/15/2021) |
NOTICE OF SERVICE of 1. Expert Report of Dr. Igor Gonda 2. Expert Report of Dr. Nicholas Hill 3. Opening Expert Report of Dr. Jeffrey Winkler filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 10/15/2021) |
NOTICE OF SERVICE of (1) Initial Expert Report of Andrew Clark, Ph.D., (2) Initial Expert Report of Colin Nuckolls, Ph.D., (3) Expert Report of Cesar Matto, (4) Initial Expert Report of Aaron Waxman, M.D., Ph.D., and (5) Expert Report of F. Dean Toste, Ph.D. on Infringement of U.S. Patent No. 9,593,066 - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 10/18/2021) |
REDACTED VERSION of 206 Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 10/19/2021) |
NOTICE of Response to Request for International Judicial Assistance by United Therapeutics Corporation (Flynn, Michael) (Entered: 10/19/2021) |
STIPULATION TO EXTEND TIME to submit proposed public versions of the parties' respective discovery dispute letters (D.I. 207 and 208) to October 21, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 10/20/2021) |
REDACTED VERSION of 208 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 10/21/2021) |
MOTION for Teleconference to Resolve Expert Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) (Entered: 10/27/2021) |
NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s First Supplemental Responses to Plaintiff United Therapeutics Corporation's Third Set of Interrogatories (Nos. 11-12) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 10/27/2021) |
Letter to The Honorable Jennifer L. Hall from Michael J. Flynn regarding Deposition of Patrick Poisson. (Flynn, Michael) (Entered: 11/02/2021) |
REDACTED VERSION of 225 Opening Brief in Support, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Main Document 228 replaced on 11/12/2021) (nms). (Entered: 11/09/2021) |
NOTICE requesting Clerk to remove David M. Fry as co-counsel.. (Keller, Karen) (Entered: 11/09/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter (D.I. 226) to November 17, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 11/10/2021) |
MOTION for Teleconference to Resolve Discovery Dispute Related to Plaintiff's Subpoena to LGM Pharma, LLC - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 11/12/2021 (nms). (Entered: 11/12/2021) |
NOTICE OF SERVICE of 1. Rebuttal Expert Report of John Fusion Addressing the Expert Report of Cesar Matto 2. Rebuttal Expert Report of Dr. Nicholas Hill in Response to the Initial Expert Reports of Dr. Aaron Waxman and Dr. Andrew Clark 3. Rebuttal Expert Report of Dr. Jeffrey Winkler on the Issue of Non-Infringement and Addressing the Expert Reports of Drs. Nuckolls and Toste. filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 11/15/2021) |
STIPULATION TO EXTEND TIME for Plaintiff United Therapeutics Corporation to file its Answering Brief in Opposition to Defendant Liquidia Technologies, Inc.'s Motion for Leave to Move for Summary Judgment (D.I. 224) to November 23, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 11/17/2021) |
ORDER: Plaintiff's Motion for Leave to File a Second Amended Complaint (D.I. 109 ) is DENIED. Signed by Judge Richard G. Andrews on 11/17/2021. (nms) (Entered: 11/17/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter to November 18, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 11/17/2021) |
REDACTED VERSION of 226 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 11/18/2021) |
MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent No. 9,593,066 and U.S. Patent No.9,604,901. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 11/18/2021. (nms) (Entered: 11/18/2021) |
NOTICE to Take Deposition of Werner Seeger on December 17, 2021 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 11/23/2021) |
PROPOSED Claim Construction Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 11/23/2021 (nms). (Entered: 11/23/2021) |
CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 11/23/2021. (nms) (Entered: 11/23/2021) |
REDACTED VERSION of 237 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 11/24/2021) |
STIPULATION TO EXTEND TIME for defendant Liquidia Technologies, Inc. to file a reply brief in support of its Motion for Leave to Move for Summary Judgment (D.I. 224) to December 7, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 11/29/2021) |
MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan) (Entered: 11/29/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public versions - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 12/1/2021 (nms). (Entered: 11/30/2021) |
STIPULATION TO EXTEND TIME to submit proposed public versions of the parties respective discovery dispute letters (D.I. 254 and 255) to December 13, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/09/2021) |
MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 12/10/2021 (ceg). (Entered: 12/10/2021) |
NOTICE to Take Deposition of Pilar Wyman on December 16, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 12/13/2021) |
NOTICE OF SERVICE of 1. Expert Report of Omar Robles, Ph.D.; 2. Reply Expert Report of Dr. Igor Gonda; 3. Reply Expert Report of Dr. Jeffrey Winkler; 4.Reply Expert Report of Dr. Nicholas Hill Regarding Invalidity of U.S. Patent No. 10,716,793; and 5. Expert Report of Dr. Sylvia Hall-Ellis Addressing the Rebuttal Expert Report of Ms. Pilar Wyman filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 12/13/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public version of United Therapeutics Corporation's Letter in Response to Liquidia Technology Inc.'s December 2, 2021 Letter to December 15, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 12/13/2021) |
REDACTED VERSION of 254 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/13/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s Reply Brief in Support of its Motion for Leave (D.I. 257) to December 17, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/14/2021) |
STIPULATION TO EXTEND TIME to submit a proposed public version of United Therapeutics Corporation's Letter in Response to Liquidia Technology Inc.'s December 2, 2021 Letter to December 16, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 12/15/2021) |
STIPULATION to Extend Time to submit a public version of Reply Brief (D.I. 257) to December 21, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 12/20/2021 (nms). Modified on 12/20/2021 (nms). (Entered: 12/17/2021) |
REDACTED VERSION of 257 Reply Brief by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/21/2021) |
REDACTED VERSION of 265 Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/21/2021) |
NOTICE OF SERVICE of Supplemental Rebuttal Expert Report of Dr. Jeffrey Winkler on the Issue of Non-Infringement and Addressing the Supplemental Opening Expert Report of Dr. Toste filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 12/27/2021) |
STIPULATION of Partial Judgment of Non-Infringement by United Therapeutics Corporation. (Flynn, Michael) (Entered: 12/28/2021) |
MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 12/28/2021) |
SO ORDERED Granting 276 Stipulation of Partial Judgment of Non-Infringement. Signed by Judge Richard G. Andrews on 1/3/2022. (nms) (Entered: 01/03/2022) |
Official Transcript of Discovery Dispute Teleconference held on 11/18/21 before Judge Jennifer L. Hall. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/25/2022. Redacted Transcript Deadline set for 2/4/2022. Release of Transcript Restriction set for 4/4/2022. (Triozzi, Heather) (Entered: 01/04/2022) |
MOTION for Pro Hac Vice Appearance of Attorney Adam Pivovar - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 01/05/2022) |
STIPULATION TO EXTEND TIME - (1) for Plaintiff United Therapeutics Corporation to file its response to Defendant Liquidia Technologies, Inc.'s Motion for Summary Judgment (D.I. 281) and (2) for Liquidia to file its reply brief to January 28, 2022 and February 11, 2022, respectively - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 01/11/2022) |
STIPULATION TO EXTEND TIME to take the depositions of Plaintiff's expert witnesses Cesar Matto and Hugh Smyth to January 21, 2022, and January 19, 2022, respectively - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 01/14/2022) |
STIPULATION TO EXTEND TIME for Defendant Liquidia Technologies, Inc. to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 21, 2022 - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 01/14/2022) |
Official Transcript of Discovery Conference held on 12/6/21 before Judge Jennifer L. Hall. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/4/2022. Redacted Transcript Deadline set for 2/14/2022. Release of Transcript Restriction set for 4/14/2022. (Triozzi, Heather) (Entered: 01/14/2022) |
STIPULATION TO EXTEND TIME for Defendant Liquidia Technologies, Inc. to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 28, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 01/21/2022) |
STIPULATION and [Proposed] Order for Pretrial Exchanges - by United Therapeutics Corporation. (Flynn, Michael) (Entered: 01/28/2022) |
REDACTED VERSION of 282 Opening Brief in Support, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 1/31/2022 (nms). (Entered: 01/28/2022) |
[SEALED] ANSWERING BRIEF in Opposition re 281 MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel - filed by United Therapeutics Corporation.Reply Brief due date per Local Rules is 2/4/2022. (Flynn, Michael) (Entered: 01/28/2022) |
[SEALED] DECLARATION of Mahdi Fawzi re 290 Answering Brief in Opposition, by United Therapeutics Corporation. (Flynn, Michael) Modified on 1/31/2022 (nms). (Entered: 01/28/2022) |
[SEALED] DECLARATION of David A. Walsh, Ph.D. re 290 Answering Brief in Opposition, by United Therapeutics Corporation. (Flynn, Michael) Modified on 1/31/2022 (nms). (Entered: 01/28/2022) |
SO ORDERED Granting 288 Stipulation and Proposed Order for Pretrial Exchanges. Signed by Judge Richard G. Andrews on 1/31/2022. (nms) (Entered: 01/31/2022) |
REDACTED VERSION of 290 Answering Brief in Opposition, by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 02/04/2022) |
REDACTED VERSION of 291 Declaration by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 02/04/2022) |
REDACTED VERSION of 292 Declaration by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 02/04/2022) |
MOTION for Pro Hac Vice Appearance of Attorney Kyung Taeck Minn - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 02/08/2022) |
NOTICE requesting Clerk to remove Joel Broussard as co-counsel. Reason for request: no longer with the firm. (Flynn, Michael) (Entered: 02/09/2022) |
MOTION for Teleconference regarding Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan) (Entered: 02/09/2022) |
[SEALED] Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding Liquidia's February 14, 2022 letter (D.I. 305 ). (Flynn, Michael) Modified on 2/16/2022 (nms). (Entered: 02/16/2022) |
Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding request for oral argument. (Hoeschen, Nathan) Modified on 2/18/2022 (nms). (Entered: 02/18/2022) |
REDACTED VERSION of 303 Reply Brief, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 02/18/2022) |
MOTION for Presumption Under 35 U.S.C § 295 - filed by United Therapeutics Corporation.(Flynn, Michael) Modified on 2/24/2022 (nms). (Entered: 02/22/2022) |
[SEALED] OPENING BRIEF in Support re 311 MOTION for Presumption Under 35 U.S.C § 295 - filed by United Therapeutics Corporation.Answering Brief/Response due date per Local Rules is 3/8/2022. (Flynn, Michael) (Entered: 02/22/2022) |
[SEALED] DECLARATION of John Kim re 312 Opening Brief in Support, by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/23/2022 (nms). (Entered: 02/22/2022) |
STIPULATION TO EXTEND TIME to file a redacted version of its Opening Discovery Dispute Letter to February 25, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 02/22/2022) |
DECLARATION of Kyung Taeck Minn re 303 Reply Brief, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 2/23/2022 (nms). (Entered: 02/23/2022) |
REDACTED VERSION of 306 Letter by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 02/23/2022) |
REDACTED VERSION of 305 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 02/23/2022) |
[SEALED] MOTION in Limine to Exclude Portions of Dr. Mahdi Fawzi's Rebuttal Expert Report - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 3/1/2022 (nms). (Entered: 02/28/2022) |
[SEALED] MOTION in Limine No. 1 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 3/1/2022 (nms). (Entered: 02/28/2022) |
[SEALED] MOTION in Limine No. 2 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 3/1/2022 (nms). (Entered: 02/28/2022) |
CERTIFICATE OF SERVICE of (1) Plaintiff's Motion in Limine No. 1 (D.I. 323) and (2) Plaintiff's Motion in Limine No. 2 (D.I. 325) - by United Therapeutics Corporation (Flynn, Michael) (Entered: 03/01/2022) |
STIPULATION TO EXTEND TIME to file an answering brief in opposition to Plaintiffs Motion for Presumption Under 35 U.S.C. § 295 (D.I. 311) to March 11, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 03/01/2022) |
STIPULATION to Extend Time to submit redacted filings to March 8, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/2/2022 (nms). (Entered: 03/01/2022) |
ORDER AFTER PRETRIAL CONFERENCE: The Proposed Pretrial Order is ADOPTED as modified by any discussion at the pretrial conference. The parties were requested to submit a revised pretrial order by the end of next week. A bench trial will begin on March 28, 2022, at 8:30 a.m. Each party should be prepared to present its case until 5:00 p.m. of each trial day, although the end of the trial day may, in the discretion of the Court, be earlier than 5:00 p.m.. The trial is timed. Each side is allowed 10 hours for its opening statement and its direct and cross-examination of witnesses (see Order for further details). Signed by Judge Richard G. Andrews on 3/4/2022. (nms) (Entered: 03/04/2022) |
ORDER ON MOTION IN LIMINE: Plaintiff's MIL #1 (D.I. 323 ) is GRANTED. Plaintiff's MIL #2 (D.I. 325 ) is DENIED. Defendant's MIL (D.I. 320 ) is GRANTED in part, DENIED in part, and LEFT OPEND in part (see Order for further details). Signed by Judge Richard G. Andrews on 3/4/2022. (nms) (Entered: 03/04/2022) |
NOTICE requesting Clerk to remove Jeffrey T. Castellano as co-counsel.. (Hoeschen, Nathan) (Entered: 03/04/2022) |
REDACTED VERSION of 320 MOTION in Limine to Exclude Portions of Dr. Mahdi Fawzi's Rebuttal Expert Report by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 03/07/2022) |
STIPULATION to Extend Time to submit proposed public versions of the Joint Proposed Pretrial Order (D.I. 322), as well as motions in limine and accompanying exhibits (D.I. 323-326) to March 18, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/8/2022 (nms). (Entered: 03/07/2022) |
REDACTED VERSION of 312 Opening Brief in Support by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/08/2022) |
REDACTED VERSION of 315 Declaration by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/08/2022) |
[SEALED] ANSWERING BRIEF in Opposition re 311 MOTION for Presumption Under 35 U.S.C § 295 filed by Liquidia Technologies, Inc..Reply Brief due date per Local Rules is 3/15/2022. (Hoeschen, Nathan) (Entered: 03/08/2022) |
STIPULATION to Extend Time - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 3/11/2022 (nms). (Entered: 03/10/2022) |
[SEALED] Proposed Joint Pretrial Order After Pretrial Conference, by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/14/2022 (nms). (Entered: 03/11/2022) |
[SEALED] Amended Exhibits 8-9 to 350 Joint Pretrial Order, by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/14/2022 (nms). (Entered: 03/11/2022) |
[SEALED] REPLY BRIEF re 311 MOTION for Presumption Under 35 U.S.C § 295 - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 03/14/2022) |
STIPULATION to Extend Time to submit proposed public versions to March 22, 2022 - filed by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/15/2022 (nms). (Entered: 03/15/2022) |
STIPULATION [and Proposed Order] regarding evidence of non-infrigment and invalidity of the asserted claims of the '901 patent at trial by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 03/16/2022) |
SO ORDERED Granting 355 Stipulation and Order. Signed by Judge Richard G. Andrews on 3/17/2022. (nms) (Entered: 03/17/2022) |
REDACTED VERSION of 348 Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 03/17/2022) |
REDACTED VERSION of 332 Exhibit to a Document by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 03/18/2022) |
REPORT AND RECOMMENDATION re 281 Defendant`s Motion for Summary Judgment of Invalidity of the `066 and `901 Patents due to Collateral Estoppel. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 4/1/2022). Signed by Judge Jennifer L. Hall on 3/18/2022. (ceg) (Entered: 03/18/2022) |
REDACTED VERSION of 325 MOTION in Limine No. 2 by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/18/2022) |
REDACTED VERSION of 350 Proposed Pretrial Order by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/18/2022) |
REDACTED VERSION of 351 Exhibit to a Document by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/18/2022) |
REDACTED VERSION of 322 Proposed Pretrial Order by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/18/2022) |
STIPULATION TO EXTEND TIME to submit proposed public versions of United Therapeutics Corporation`s Motion in Limine No. 1 and accompanying exhibits (D.I. 323-324) to March 22, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/18/2022) |
Official Transcript of Pretrial Conference held on 3/4/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/11/2022. Redacted Transcript Deadline set for 4/21/2022. Release of Transcript Restriction set for 6/21/2022. (Triozzi, Heather) (Entered: 03/21/2022) |
MOTION for Pro Hac Vice Appearance of Attorney Ian B. Brooks - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 03/21/2022) |
MOTION for Pro Hac Vice Appearance of Attorney Eric Levi - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 03/21/2022) |
REDACTED VERSION of 352 Reply Brief by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/21/2022) |
REDACTED VERSION of 323 MOTION in Limine No. 1 by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/22/2022) |
MEMORANDUM. Signed by Judge Richard G. Andrews on 3/22/2022. (nms) (Entered: 03/22/2022) |
ORDER: Plaintiff`s Motion for Presumption Under 35 U.S.C § 295 (D.I. 311 ) is DENIED. Signed by Judge Richard G. Andrews on 3/22/2022. (nms) (Entered: 03/22/2022) |
STIPULATION to Extend Time to File Redacted Filing to March 25, 2022 - filed by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/23/2022 (nms). (Entered: 03/22/2022) |
[SEALED] OBJECTION to 360 Report and Recommendations by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 03/23/2022) |
Letter to Honorable Richard G. Andrews from Michael J. Flynn regarding copies of the requested pictures of plaintiff`s witnesses and pages from the expert witnesses` curricula vitae. (Flynn, Michael) (Entered: 03/24/2022) |
REDACTED VERSION of 343 Answering Brief in Opposition by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 03/25/2022) |
REDACTED VERSION of 344 Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 03/25/2022) |
REDACTED VERSION of 345 Declaration, by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/28/2022 (nms). (Entered: 03/25/2022) |
STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.`s Objection to Report and Recommendation (D.I. 377) to April 13, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) (Entered: 03/30/2022) |
STIPULATION to Extend Time to file its response to Objections to Report & Recommendation to April 13, 2022 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/1/2022 (nms). (Entered: 04/01/2022) |
REDACTED VERSION of 344 Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 04/04/2022) |
[SEALED] DECLARATION of Kyung Taeck Minn re 385 Redacted Declaration, by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 4/5/2022 (nms). (Entered: 04/04/2022) |
Witness list for Bench Trial held on 3/28/2022 - 3/31/2022. (lak) (Main Document 388 replaced on 4/12/2022) (lak). (Entered: 04/05/2022) |
Official Transcript of Report and Recommendation held on 03/11/22 before Judge Jennifer L. Hall. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/28/2022. Redacted Transcript Deadline set for 5/9/2022. Release of Transcript Restriction set for 7/6/2022. (Triozzi, Heather) (Entered: 04/07/2022) |
STIPULATION TO EXTEND TIME to submit a final list of exhibits admitted at trial to April 8, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/07/2022) |
STIPULATION To Extend Time to submit a final list of exhibits admitted at trial to April 11, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 4/11/2022 (nms). (Entered: 04/08/2022) |
REDACTED VERSION of 386 Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily) (Entered: 04/11/2022) |
Admitted Exhibit List, by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 4/12/2022 (nms). (Entered: 04/11/2022) |
REDACTED VERSION of 377 Objection to Report and Recommendations by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/13/2022) |
RESPONSE to 377 Objections, by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/14/2022 (nms). (Entered: 04/13/2022) |
STIPULATION and [Proposed] Order on Post-Trial Briefing - by United Therapeutics Corporation. (Flynn, Michael) (Entered: 04/18/2022) |
SO ORDERED Granting 399 Stipulation and Proposed Order on Post-Trial Briefing. Signed by Judge Richard G. Andrews on 4/18/2022. (nms) (Entered: 04/18/2022) |
NOTICE of Change of Address by Nathan Roger Hoeschen (Hoeschen, Nathan) (Entered: 04/25/2022) |
Official Transcript of Bench Trial held on 3/28/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather) (Entered: 05/02/2022) |
Official Transcript of Bench Trial held on 3/29/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather) (Entered: 05/02/2022) |
Official Transcript of Bench Trial held on 3/30/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather) (Entered: 05/02/2022) |
Official Transcript of Bench Trial held on 3/31/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather) (Entered: 05/02/2022) |
POST-TRIAL Opening Brief Regarding Invalidity of U.S. Patent Nos. 9,593,066 and 10,716,793, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 5/5/2022 (nms). (Entered: 05/04/2022) |
Proposed Findings of Fact by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 05/04/2022) |
POST-TRIAL Opening Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/5/2022 (nms). (Entered: 05/04/2022) |
Proposed Findings of Fact by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/04/2022) |
MEMORANDUM ORDER: The Report & Recommendation (D.I. 360 ) is ADOPTED to the extent necessary as to the above discussion. Liquidia`s Motion for Summary Judgment (D.I. 281 ) is DENIED. Signed by Judge Richard G. Andrews on 5/12/2022. (nms) (Entered: 05/12/2022) |
Post-Trial Answering Brief Regarding Non-Infringement, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/2/2022 (nms). (Entered: 06/01/2022) |
Proposed Findings of Fact by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 06/01/2022) |
Answering Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/2/2022 (nms). (Entered: 06/01/2022) |
Proposed Findings of Fact by United Therapeutics Corporation. (Flynn, Michael) (Entered: 06/01/2022) |
Post-Trial Reply Brief Regarding Invalidity of U.S. Patent Nos. 9,593,066 and 10,716,793, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/15/2022 (nms). (Main Document 415 replaced on 6/16/2022) (nms). (Entered: 06/15/2022) |
Reply Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/15/2022 (nms). (Entered: 06/15/2022) |
Letter to The Honorable Richard G. Andrews from Michael Flynn regarding Plaintiffs` Hyperlinked Post Trial Briefs. (Flynn, Michael) (Entered: 06/22/2022) |
NOTICE of filing Defendant`s Hyperlinked Post-Trial Opening Brief (D.I. 406 and 407); Defendant`s Hyperlinked Post-Trial Answering Brief (D.I. 411 and 412); Defendant`s Hyperlinked Post-Trial Reply (D.I. 415). Original Non-paper material(s) to be filed with the Clerk`s Office. Notice, filed by Nathan Roger Hoeschen on behalf of Liquidia Technologies, Inc. (Hoeschen, Nathan) Modified on 6/22/2022 (nms). (Entered: 06/22/2022) |
Official Transcript of Summary Judgment Videoconference held on 3/10/22 before Judge Jennifer L. Hall. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/4/2022. Redacted Transcript Deadline set for 8/15/2022. Release of Transcript Restriction set for 10/12/2022. (Triozzi, Heather) (Entered: 07/14/2022) |
Letter to The Honorable Richard G. Andrews, from Karen E. Keller, regarding the PTAB`s final written decision. (Keller, Karen) Modified on 8/16/2022 (nms). (Entered: 08/15/2022) |
NOTICE of Withdrawal of Counsel Sarah E. Simonetti, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/19/2022 (nms). (Entered: 08/19/2022) |
Letter to The Honorable Richard G. Andrews, from Michael Flynn regarding Liquidia`s request that the Court stay its decision on the `793 patent (D.I. 430 ). (Flynn, Michael) Modified on 8/26/2022 (nms). (Entered: 08/26/2022) |
ORDER: Liquidia`s stay request (D.I. 427 at 3) is DENIED. Signed by Judge Richard G. Andrews on 8/30/2022. (nms) (Entered: 08/30/2022) |
TRIAL OPINION. Signed by Judge Richard G. Andrews on 8/31/2022. (nms) (Entered: 08/31/2022) |
FINAL JUDGMENT (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/9/2022. (nms) (Entered: 09/09/2022) |
Timeline
filed_date
closed_date
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2023
Feb
Mar
Apr
May
Patents In Case